Progress Pulse

Short summaries of scientific findings from across the St. Jude research enterprise.

Targeting oncofetal tenascin C with immunotherapy requires a signal boost

Adding activation signals improves solid and brain tumor immunotherapy.

St. Jude co-led multi-institution collaboration uncovers a predisposition gene for osteosarcoma

St. Jude scientists have discovered a new predisposition gene in a type of pediatric bone cancer.